On 12 November 2016
Marksans Pharma will hold a meeting of the Board of Directors of the Company on 12 November 2016 to consider and approve Unaudited Financial Results of the Company (both Standalone and Consolidated) for the Second Quarter ended on 30 September 2016 (Q2).Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
